Alnylam US Inc is categorized under Commercial Medical Research in Cambridge, MA and active since 2002.
Alnylam US Inc was established in 2002, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact John Maraganore, Chief Executive Officer at the company’s single location by writing to 300 3rd St # 3, Cambridge, Massachusetts MA 02142 or by phoning (617) 551-8200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Alnylam US Inc |
| Contact Person: | John Maraganore, Chief Executive Officer |
| Address: | 300 3rd St # 3, Cambridge, Massachusetts 02142 |
| Phone Number: | (617) 551-8200 |
| Website Address: | alnylam.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 3254120 |
| Share This Business: |
Alnylam US Inc was started in 2002 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact John Maraganore, Chief Executive Officer for inquiries that concern Alnylam US Inc by calling the company number (617) 551-8200, as your correspondence is most welcome. Additionally, the physical location of the single location of Alnylam US Inc can be found at the coordinates 42.36698,-71.08159 as well as the street address 300 3rd St # 3 in Cambridge, Massachusetts 02142.
For its online presence, you may visit Alnylam US Inc’s website at alnylam.com and engage with its social media outlets through on Twitter and on Facebook.